25 research outputs found

    The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

    Get PDF
    Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

    Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

    Get PDF
    The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.Funding/Support: The Institute for Health Metrics and Evaluation received funding from the Bill & Melinda Gates Foundation and the American Lebanese Syrian Associated Charities. Dr Aljunid acknowledges the Department of Health Policy and Management of Kuwait University and the International Centre for Casemix and Clinical Coding, National University of Malaysia for the approval and support to participate in this research project. Dr Bhaskar acknowledges institutional support from the NSW Ministry of Health and NSW Health Pathology. Dr Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, which is funded by the German Federal Ministry of Education and Research. Dr Braithwaite acknowledges funding from the National Institutes of Health/ National Cancer Institute. Dr Conde acknowledges financial support from the European Research Council ERC Starting Grant agreement No 848325. Dr Costa acknowledges her grant (SFRH/BHD/110001/2015), received by Portuguese national funds through Fundação para a Ciência e Tecnologia, IP under the Norma Transitória grant DL57/2016/CP1334/CT0006. Dr Ghith acknowledges support from a grant from Novo Nordisk Foundation (NNF16OC0021856). Dr Glasbey is supported by a National Institute of Health Research Doctoral Research Fellowship. Dr Vivek Kumar Gupta acknowledges funding support from National Health and Medical Research Council Australia. Dr Haque thanks Jazan University, Saudi Arabia for providing access to the Saudi Digital Library for this research study. Drs Herteliu, Pana, and Ausloos are partially supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. Dr Hugo received support from the Higher Education Improvement Coordination of the Brazilian Ministry of Education for a sabbatical period at the Institute for Health Metrics and Evaluation, between September 2019 and August 2020. Dr Sheikh Mohammed Shariful Islam acknowledges funding by a National Heart Foundation of Australia Fellowship and National Health and Medical Research Council Emerging Leadership Fellowship. Dr Jakovljevic acknowledges support through grant OI 175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. Dr Katikireddi acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government Chief Scientist Office (SPHSU17). Dr Md Nuruzzaman Khan acknowledges the support of Jatiya Kabi Kazi Nazrul Islam University, Bangladesh. Dr Yun Jin Kim was supported by the Research Management Centre, Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). Dr Koulmane Laxminarayana acknowledges institutional support from Manipal Academy of Higher Education. Dr Landires is a member of the Sistema Nacional de Investigación, which is supported by Panama’s Secretaría Nacional de Ciencia, Tecnología e Innovación. Dr Loureiro was supported by national funds through Fundação para a Ciência e Tecnologia under the Scientific Employment Stimulus–Institutional Call (CEECINST/00049/2018). Dr Molokhia is supported by the National Institute for Health Research Biomedical Research Center at Guy’s and St Thomas’ National Health Service Foundation Trust and King’s College London. Dr Moosavi appreciates NIGEB's support. Dr Pati acknowledges support from the SIAN Institute, Association for Biodiversity Conservation & Research. Dr Rakovac acknowledges a grant from the government of the Russian Federation in the context of World Health Organization Noncommunicable Diseases Office. Dr Samy was supported by a fellowship from the Egyptian Fulbright Mission Program. Dr Sheikh acknowledges support from Health Data Research UK. Drs Adithi Shetty and Unnikrishnan acknowledge support given by Kasturba Medical College, Mangalore, Manipal Academy of Higher Education. Dr Pavanchand H. Shetty acknowledges Manipal Academy of Higher Education for their research support. Dr Diego Augusto Santos Silva was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil Finance Code 001 and is supported in part by CNPq (302028/2018-8). Dr Zhu acknowledges the Cancer Prevention and Research Institute of Texas grant RP210042

    New approach to the synthesis of C-glycosides, azasugars, and aza C-glycosides

    No full text
    Synthesis of sugar analogs in which the ring oxygen atom has been replaced by an-NR-group (azasugars) and/or the anomeric hydroxyl group has been replaced by a carbon atom (C-glycosides) has been a subject of intensive research interest in recent years. Many members of both classes of compounds are specific inhibitors of glycosidases, including enzymes involved in glycoprotein processing, glycogenolysis, and oligo- and disaccharide hydrolysis. In spite of recent developments in the synthesis of C-glycosides and azasugars, the stereospecific formation C-glycosides and aza C-glycosides remains a challenge for synthetic carbohydrate chemistry. A simple way to prepare C-glycosides and aza C-glycosides of D-arabinose and D-lyxose, that can be applied to other aldoses, is reported. The reaction involves oxidation of D-glucose diethyl dithioacetal (with spontaneous cyclization) to the corresponding (α\alpha-D-arabinopyranosyl)-di(ethyl sufonyl)methane. Reduction to the diethyl dithioacetal of (α\alpha-D arabinosyl) formaldehyde, and converting it to an aldhehyde provides a compound which can be modified to other desired products. Oxidation of a protected 6-amino-6-deoxy-D-galactose diethyl dithioacetal provided the corresponding azasugars

    Critical pressure asymmetry in the enclosed fluid diode

    Get PDF
    Joint physically and chemically pattered surfaces can provide efficient and passive manipulation of fluid flow. The ability of many of these surfaces to allow only unidirectional flow mean they are often referred to as fluid diodes. Synthetic analogues of these are enabling technologies from sustainable water collection via fog harvesting, to improved wound dressings. One key fluid diode geometry features a pore sandwiched between two absorbent substrates, an important design for applications which require liquid capture while preventing back-flow. However, the enclosed pore is particularly challenging to design as an effective fluid diode, due to the need for both a low Laplace pressure for liquid entering the pore, and a high Laplace pressure to liquid leaving. Here, we calculate the Laplace pressure for fluid travelling in both directions on a range of conical pore designs with a chemical gradient. We show that this chemical gradient is in general required to achieve the largest critical pressure differences between incoming and outgoing liquids. Finally, we discuss the optimisation strategy to maximise this critical pressure asymmetry

    Prevalence and risk factors of bovine tuberculosis in cattle in selected districts of Fafan pastoral settings, Eastern Ethiopia

    No full text
    Cross-sectional study was conducted from October 2021 to August 2022 to investigate the prevalence and associated risk factors of bovine tuberculosis in cattle in selected districts of the pastoral settings of Fafan zone, Somali region, eastern Ethiopia. A comparative intradermal tuberculin test was performed using purified protein derivatives. Animal-related characteristics, and the owner's knowledge on the importance of BTB were collected using a structured questionnaire. The prevalence was 11.24 % (95 % CI, 8.61–14.35) and 43.3 % (95 % CI, 33.27–53.75) at the individual and herd levels, respectively. There were statistically significant differences in the proportions of positive reactor animals according to body condition score (P = 0.000), age (P = 0.048), seasonal migration (P = 0.038), parity number (P = 0.005), and reproductive status (P = 0.037). Animals with poor body condition scores had a significantly higher likelihood of testing positive, with their odds being 11.4 times greater (COR = 11.408, CI = 3.43–37.94, P < 0.001). In multivariate logistic regression, poor body condition score remained significantly associated with the odds of a positive reaction to tuberculosis (AOR = 0.137, CI = 0.053–0.356, P < 0.001). Similarly, the analysis showed that seasonal migration (AOR = 2.882, CI = 1.155–7.191, P = 0.023) and parity number (AOR = 11.64, CI = 1.818–74.464, P = 0.010) were significant predictors of bovine tuberculosis infection in cattle. According to the questionnaire, 14.2 % (17 of 120) and 13.3 % (16 of 120) of the respondents were knowledgeable about bovine tuberculosis and its transmission from animals to humans, and vice versa, respectively. The general judgment of herders' understanding of bovine tuberculosis transmission methods to humans was very low. The study findings showed a high prevalence of bovine tuberculosis in the study area, emphasizing the need for an effective control and prevention strategy

    Pathological Observations in Horses Naturally Infected with Trypanosoma equiperdum in Western Arsi Zone, Ethiopia

    No full text
    Dourine, a venereal transmitted trypanosomosis is endemic in Ethiopia and it is the major health problem threatening equines. Until recently only few studies were conducted on pathological tissue changes associated with T. equiperdum infection in horses. A cross-sectional study design and purposive sampling were used from November 2014 to June 2015 to identify and select dourine infected horses. Out of 480 (201 mares and 279 stallions) totally examined horses, only twelve mares were positive. Despite attempts made to isolate the parasite using Woo test, no trypanosomes were detected in all of examined blood samples. From the twelve positive mares, two severely affected mares (M1 and M2) with history of sexual infection and suggestive clinical signs as well as serologically positive by CATT/RoTat 1.2 test were purchased and euthanized for postmortem examination. Gross lesions observed in the two euthanized infected mares include, swollen vulva with visible areas of depigmentation, congestion of the mucosa of vagina, thickened and congested mucosa of uterus, ovarian follicular cysts, slightly enlarged and congested spleen, enlarged and swollen liver with multiple necrotic foci. Microscopically, mononuclear cell infiltration mainly of lymphocytes and plasma cells and periglandular inflammation were observed in the vulva, vagina, cervix and uterus. In addition, interstitial mastitis, haemosidrin deposition in the spleen and liver and lymphocytes depletion in the spleen were observed. The gross and histological findings indicated the presence of various organs involvement with severe degree of lesions. Therefore, experimental infections of natural hosts, and unnatural hosts with trypanosome obtained direct from the natural host is recommended in order to study the pathology of dourine in detail in the future

    Forming nanostructured surfaces through Janus colloidal silica particles with nanowrinkles: A new strategy to superhydrophobicity

    No full text
    Proper nano-structuring coupled with low surface energy properties is exploited to obtain super-hydrophobic surfaces. A biomimicking hierarchically structured coating upon a material surface is obtained by depositing Janus nano-structured wrinkled colloidal particles. The morphology of the surface is thus ruled by different scales: the size of the wrinkles (few tens of nanometer), particle radius (several hundreds of nanometer) and interparticle distance. Janus wrinkled silica particles have one side exposing hydroxyl groups while the other side is partially silanized with dichlorodimethylsilane. To obtain these Janus particles, wax colloidosomes with surface covered by starting rough particles were successfully prepared. The exposed surface of rough wrinkled silica particles was then silanized, thus obtaining a Janus structure. The Janus character was prooved in different manners: the simple so called “visual test”, through Energy Filtered Transmission Electron Microscopy (was proven in different EFTEM) and by further functionalization with polypropylene grafted maleic anhydride (PPgMA). A glass microscope slide was covered by drop casting the particles obtaining super-hydrophobic features of the surface characterized by a high water contact angle (149°) and, more interestingly, by a very low water contact angle hysteresis (CAH=2°) and roll-off angle (ROA=1.8°). Superhydrophobicity is confirmed by the very low values of apparent surface free energy estimated with the OWRK (Owens-Wendt-Rabel e Kaelble) method. SEM and AFM analyses prove the multiple scale hierarchical roughness, from nano to micro size, that resembles the one present at the surface of the lotus leaves
    corecore